Mosapride

Drug Profile

Mosapride

Alternative Names: AS 4370; Gasmotin; Mosafe; TAK 370

Latest Information Update: 10 Sep 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Dainippon Sumitomo Pharma
  • Developer Eisai Co Ltd
  • Class Antiulcers; Benzamides; Gastrokinetics; Morpholines; Small molecules
  • Mechanism of Action Serotonin 4 receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Marketed Dyspepsia; Gastritis
  • No development reported Non-ulcer dyspepsia
  • Discontinued Gastro-oesophageal reflux; Gastrointestinal disorders

Most Recent Events

  • 15 Dec 2016 Biomarkers information updated
  • 19 Jun 2014 Dainippon Sumitomo Pharma is now called Sumitomo Dainippon Pharma
  • 30 Jul 2010 Preregistration for Gastritis in Laos (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top